Verge Genomics is seeking a highly motivated individual to spearhead pre-clinical development of disease modifying treatments for neurodegenerative diseases. You will be responsible for advancing our current and emerging lead candidate pipeline through all stages of pre-clinical development, acting as a leader of multidisciplinary project teams. You will oversee important external collaborations with contract research organizations (CROs), leading academic groups, non-profits, and pharmaceutical partners. As one of the first employees at Verge, you will develop help build the foundation of a revolutionary drug development model.
- Manages and leads multiple projects evaluating efficacy of small molecules for treatment of Alzheimer’s Disease, ALS, and Parkinson’s Disease
- Identifies, engages, and manages external collaborations with CROS, leading academic groups, and patient advocacy organizations
- Generate and implement pre-clinical development plans with aggressive timelines that are well-designed, rigorous, and cost-efficient
- Maintain strong relationships with pharmaceutical partners and key opinion leaders, with emphasis on understanding their needs and adapting research strategy accordingly